| Literature DB >> 23940276 |
Colleen Doyle-Cooper1, Krystalyn E Hudson1, Anthony B Cooper1, Takayuki Ota1, Patrick Skog1, Phillip E Dawson2, Michael B Zwick1, William R Schief1,3,4, Dennis R Burton1,3,4,5, David Nemazee1.
Abstract
A major goal of HIV research is to develop vaccines reproducibly eliciting broadly neutralizing Abs (bNAbs); however, this has proved to be challenging. One suggested explanation for this difficulty is that epitopes seen by bNAbs mimic self, leading to immune tolerance. We generated knock-in mice expressing bNAb 4E10, which recognizes the membrane proximal external region of gp41. Unlike b12 knock-in mice, described in the companion article (Ota et al. 2013. J. Immunol. 191: 3179-3185), 4E10HL mice were found to undergo profound negative selection of B cells, indicating that 4E10 is, to a physiologically significant extent, autoreactive. Negative selection occurred by various mechanisms, including receptor editing, clonal deletion, and receptor downregulation. Despite significant deletion, small amounts of IgM and IgG anti-gp41 were found in the sera of 4E10HL mice. On a Rag1⁻/⁻ background, 4E10HL mice had virtually no serum Ig of any kind. These results are consistent with a model in which B cells with 4E10 specificity are counterselected, raising the question of how 4E10 was generated in the patient from whom it was isolated. This represents the second example of a membrane proximal external region-directed bNAb that is apparently autoreactive in a physiological setting. The relative conservation in HIV of the 4E10 epitope might reflect the fact that it is under less intense immunological selection as a result of B cell self-tolerance. The safety and desirability of targeting this epitope by a vaccine is discussed in light of the newly described bNAb 10E8.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23940276 PMCID: PMC3773228 DOI: 10.4049/jimmunol.1301285
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422